Active-ingredient Dossier
Desvenlafaxine
Active-ingredient Dossier for Desvenlafaxine (serotonin norepinephrine reuptake inhibitor). Australian brands, products, PBS listings, PBAC outcomes —…
- Brand: DESFAX
- Brand: DESVENLAFAXINE
- Brand: PRISTIQ
- Brand: APO-DESVENLAFAXINE MR
- Brand: DESVEN
- Brand: DESVENLAFAXINE
- Therapeutic area: Psychiatry
What is
Desvenlafaxine Desvenlafaxine is a serotonin norepinephrine reuptake inhibitor.
Australian brands containing
Desvenlafaxine — DESFAX — DESVENLAFAXINE — DESVEN — DESVENLAFAXINE SANDOZ — DESVENLAFAXINE VIATRIS — DESVENLAFAXINE-WGR XR — MEDVEN — DESLAXA — DESVENLAFAXINE ALEMBIC
Therapeutic areas
Desvenlafaxine is registered in neurology, with nine brands containing the ingredient.
Sponsor landscape
Six sponsors market desvenlafaxine in Australia: Arrotex Pharmaceuticals, Medis Pharma, Alembic Pharmaceuticals, Sandoz, Alphapharm, and GM Pharma.
PBS and regulatory activity
Two brands containing desvenlafaxine have PBS-listed items, with the latest PBS schedule date of 1 May 2026. In the 2015–16 fiscal year, government expenditure on desvenlafaxine was $46,464,344.23 across 1,464,961 scripts.